IDXX vs. ISRG: IDEXX Laboratories vs. Intuitive Surgical Stock Comparison

Company Profile

IDEXX Laboratories (IDXX) and Intuitive Surgical (ISRG) are both classified in the Health Care Equipment sub-industry within the broader Health Care Equipment & Supplies industry, placing them in the closest GICS peer bucket.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

Both companies show strong equity returns, but IDEXX Laboratories (IDXX) at 68.93% is the standout with ROE above its industry range; Intuitive Surgical (ISRG) at 17.93% also sits in the top quartile.

For every dollar of sales, both IDEXX Laboratories (IDXX) at 25.36% and Intuitive Surgical (ISRG) at 25.54% retain more as net profit than most peers, landing in the top net margin quartile of their industries.

Both IDEXX Laboratories (IDXX) at 33.14% and Intuitive Surgical (ISRG) at 33.29% convert sales into operating profit at a top-quartile rate, pointing to tighter cost discipline before financing and tax.

Profitability Metrics

Growth

Intuitive Surgical (ISRG) at 20.51% sits in the top revenue growth quartile, while IDEXX Laboratories (IDXX) at 10.42% is closer to the peer norm — faster top-line expansion for ISRG.

Both IDEXX Laboratories (IDXX) at 22.59% and Intuitive Surgical (ISRG) at 22.59% land near their industries' usual EPS growth ranges, so bottom-line momentum looks broadly in line with peers on both sides.

Growth Metrics

Financial Strength

Intuitive Surgical (ISRG) at 3.33 keeps current ratio within its industry’s typical mid-range, while IDEXX Laboratories (IDXX) at 1.19 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for IDXX.

Only one side’s leverage can be read here: IDEXX Laboratories (IDXX) carries debt-to-equity ratio of 0.52 against its industry range, while Intuitive Surgical (ISRG) reports no figure this period.

Financial Strength Metrics

Dividends

Neither IDEXX Laboratories (IDXX) nor Intuitive Surgical (ISRG) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

Neither IDEXX Laboratories (IDXX) nor Intuitive Surgical (ISRG) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

Dividend Metrics

Valuation

IDEXX Laboratories (IDXX) at 45.56 is near its industry’s usual P/E ratio, while Intuitive Surgical (ISRG) at 54.75 sits in the richer quartile — ISRG needs stronger growth or earnings quality to justify the premium.

Investors are paying well above the peer range per dollar of sales for both IDEXX Laboratories (IDXX) at 11.42 and Intuitive Surgical (ISRG) at 13.82 — each P/S ratio clears its industry’s benchmark range.

Both look rich against book: Intuitive Surgical (ISRG) at 9.82 sits in the upper P/B ratio quartile, and IDEXX Laboratories (IDXX) at 28.50 prices even higher, above its industry range.

Valuation Metrics